Emerging evidence has shown that triacylglycerol accumulation within the myocardium may be responsible for the development of diabetes-induced heart failure, and this process is mainly modulated by transport protein fatty acid translocase CD36 (Chandler et al., 2003; Coort et al., 2004). The gene discussed is CD36; the disease is heart failure.